AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie abbVie Savings Plan — Net Investment Income ($K)
Form 11-K AbbVie Savings Plan
Latest, FY2025
2,644,533.00
Period ended Dec 31, 2025
Change on a year earlier
+52.4%
1,735,073.00 in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | AbbVie Savings Plan — Net Investment Income ($K) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,644,533.00 | +52.4% | Form 11-K (AbbVie Savings Plan) (abbv-20251231x11k.htm, filed 2026-06-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,735,073.00 | +18.8% | Form 11-K (AbbVie Savings Plan) (tm2517646d1_11k.htm, filed 2025-06-13) ↗ |
| FY2023 | Dec 31, 2023 | 1,459,900.00 | – | Form 11-K (AbbVie Savings Plan) (tm2418364d1_11k.htm, filed 2024-06-27) ↗ |
Cite this data
StockData. (2026). AbbVie AbbVie Savings Plan — Net Investment Income ($K), annual FY2023–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/plan11k_inv_inc
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.